Optimization of DNA vaccination immune responses in dairy cows: Effect of injection site and the targeting efficacy of antigen-bCTLA-4 complex

Vaccine

Volumn 21, Issue 19-20, 2003, Pages 2372-2382

  Shkreta, Lulzim ^a,b   Talbot, Brian G ^a   Lacasse, Pierre ^b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b SHERBROOKE RESEARCH AND DEVELOPMENT CENTRE   (Canada)

Author keywords

Bovine; Delivery; DNA vaccine; Targeting

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; PLASMID VECTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DAIRY CATTLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMORAL IMMUNITY; IMMUNE RESPONSE; INJECTION; INJECTION SITE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; NEEDLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING;

EID: 0038064510     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00097-5     Document Type: Article

References (41)

1. Babiuk LA, Babiuk SL, Loehr BI, van Drunnen Littel-van den Hurk S. Nucleic acid vaccines: research tool or commercial reality. Vet Immunol Immunopathol 2000;76:1-23.
2. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15:1997;617-648.
3. Dunham S. The application of nucleic acid vaccines in veterinary medicine. Res. Vet. Sci. 73:2002;9.
4. van Drunen Littel-van den Hurk S., Loehr B.I., Babiuk L.A. Immunization of livestock with DNA vaccines: current studies and future prospects. Vaccine. 19:2001;2474-2479.
5. Bennett A.M., Phillpotts R.J., Perkins S.D., Jacobs S.C., Williamson E.D. Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus. Vaccine. 18:1999;588-596.
6. Davis HL. Methods in molecular medicine, DNA vaccines: methods and protocols, vol. 29. Totowa (NJ): Humana Press; 2000. p. 71-9.
7. Hanlon L., Argyle D.J. The science of DNA vaccination. Infect. Dis. Rev. 3:2001;2-12.
8. Boyle J.S., Silva A., Brady J.L., Lew A.M. DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc Natl Acad Sci USA. 94:1997;14626-14631.
9. McCluskie M.J., Brazolot Millan C.L., Gramzinski R.A., Robinson H.L., Santoro J.C., Fuller J.T.et al. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol. Med. 5:1999;287-300.
10. Torres C.A., Iwasaki A., Barber B.H., Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158:1997;4529-4532.
11. Hohlfeld R., Engel A.G. The immunobiology of muscle. Immunol. Today. 15:1994;269-274.
12. Robinson H.L., Torres C.A. DNA vaccines. Semin. Immunol. 9:1997;271-283.
13. Barry M.A., Johnston S.A. Biological features of genetic immunization. Vaccine. 15:1997;788-791.
14. Boyle J.S., Brady J.L., Lew A.M. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature. 392:1998;408-411.
15. Deliyannis G., Boyle J.S., Brady J.L., Brown L.E., Lew A.M. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc Natl Acad Sci USA. 97:2000;6676-6680.
16. Drew D.R., Boyle J.S., Lew A.M., Lightowlers M.W., Strugnell R.A. The human IgG3 hinge mediates the formation of antigen dimers that enhance humoral immune responses to DNA immunisation. Vaccine. 19:2001a;4115-4120.
17. Drew D.R., Boyle J.S., Lew A.M., Lightowlers M.W., Chaplin P.J., Strugnell R.A. The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep. Vaccine. 19:2001;4417-4428.
18. Lew A.M., Brady B.J., Boyle B.J. Site-directed immune responses in DNA vaccines encoding ligand-antigen fusions. Vaccine. 18:2000;1681-1685.
19. Parsons K.R., Young J.R., Collins B.A., Howard C.J. Cattle CTLA-4, CD28 and chicken CD28 bind CD86: MYPPPY is not conserved in cattle CD28. Immunogenetics. 43(6):1996;388-391.
20. Mumper R.J., Rolland A.P. Plasmid delivery to muscle: Recent advances in polymer delivery systems. Adv. Drug. Deliv. Rev. 30:1998;151-172.
21. Davis W.C., Davis J.E., Hamilton M.J. Use of monoclonal antibodies and flow cytometry to cluster and analyze leukocyte differentiation molecules. Methods Mol. Biol. 45:1995;149-167.
22. SAS user's guide. Statistics, version 5, ed. Cary (NC): SAS Inst. Inc.; 1985.
23. Salmon J.K., Armstrong C.A., Ansel J.C. The skin as an immune organ. West J. Med. 160:1994;146-152.
24. Hammond S.A., Tsonis C., Sellins K., Rushlow K., Scharton-Kersten T., Colditz I.et al. Transcutaneous immunization of domestic animals: opportunities and challenges. Adv. Drug. Deliv. Rev. 43:2000;45-55.
25. Klinman D.M., Sechler J.M., Conover J., Gu M., Rosenberg A.S. Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. J. Immunol. 160:1998;2388-2392.
26. Akbari O., Panjwani N., Garcia S., Tascon R., Lowrie D., Stockinger B. DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J. Exp. Med. 189:1999;169-178.
27. Winegar R.A., Monforte J.A., Suing K.D., O'Loughlin K.G., Rudd C.J., Macgregor J.T. Determination of tissue distribution of an intramuscular plasmid vaccine using PCR and in situ DNA hybridization. Hum. Gene Therapy. 7:1996;2185-2194.
28. Donnelly J.J., Liu M.A., Ulmer J.B. Antigen presentation and DNA vaccines. Am. J. Respir. Crit. Care Med. 162:2000;S190-193.
29. Kerr D.E., Furth P.A., Powell A.M., Wall R.J. Expression of gene-gun injected plasmid DNA in the ovine mammary gland and in lymph nodes draining the injection site. Animal Biotechnol. 7:1996;33-45.
30. Paape M.J., Shafer-Weaver K., Capuco A.V., Van Oostveldt K., Burvenich C. Immune surveillance of mammary tissue by phagocytic cells. Adv. Exp. Med. Biol. 480:2000;259-277.
31. Riollet C., Rainard P., Poutrel B. Cells and cytokines in inflammatory secretions of bovine mammary gland. Adv. Exp. Med. Biol. 480:2000;247-258.
32. Capuco A.V., Akers R.M. Mammary involution in dairy animals. J. Mammary Gland Biol. Neoplasia. 4:1999;137-144.
33. Zinkernagel R.M., Ehl S., Aichele P., Oehen S., Kundig T., Hengartner H. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156:1997;199-209.
34. Ochsenbein A.F., Karrer U., Klenerman P., Althage A., Ciurea A., Shen H.et al. A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. Proc Natl Acad Sci USA. 96:1999;9293-9298.
35. Maloy K.J., Erdmann I., Basch V., Sierro S., Kramps T.A., Zinkernagel R.M.et al. Intralymphatic immunization enhances DNA vaccination. Proc Natl Acad Sci USA. 98:2001;3299-3303.
36. Vordermeier H.M., Cockle P.J., Whelan A.O., Rhodes S., Chambers M.A., Clifford D.et al. Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test. Vaccine. 19:2001;1246-1255.
37. van Drunen Littel-van den Hurk, Braun RP, Lewis PJ, Karvonen BC, Baca-Estrada ME, Snider M, McCartney D, Watts T, Babiuk LA. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J Gen Virol 1998;79:831-9.
38. Thompson C.B., Allison J.P. The emerging role of CTLA-4 as an immune attenuator. Immunity. 7:1997;445-450.
39. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle N.K., Ledbetter J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:1991;561-569.
40. Huang T.H., Wu P.Y., Lee C.N., Huang H.I., Hsieh S.L., Kung J.et al. Enhanced antitumor immunity by fusion of CTLA-4 to a self tumor antigen. Blood. 96:2000;3663-3670.
41. Chaplin P.J., De Rose R., Boyle J.S., McWaters P., Kelly J., Tennent J.M.et al. Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep. Infect Immun. 67:1999;6434-6438.